Immunotherapy Advances Journal

Immunotherapy Advances publishes from discovery through to clinical trials - now more accessible than ever thanks to read & publish.

Make your science count beyond the lab bench.

Read more about read and publish here: bit.ly/4ksUbHJ

Adding L-arginine to cell culture medium could help therapeutic T cells survive longer.

New research in Immunotherapy Advances finds improved survival of virus-specific CD8+ T cells, including after freezing and thawing.

Read more: academic.oup.com/immunotherapya…

New research in ITA suggests age related differences in how children and adults process immunoglobulin replacement therapy are unlikely to be clinically meaningful.

The findings support dosing guided by individual needs, rather than age alone.

Read more: academic.oup.com/immunotherapya…

A simple whole-blood assay enables rapid, in vivo monitoring of engineered TCR T cell function, capturing cytokine responses post-transfer without complex processing. A practical step for tracking cell therapy performance. 🧬

vist.ly/5mnx8

A step forward in evolving cell therapies for AML: integrating TCR, CAR, BiTE, and safety switch into a single engineered T cell highlights how the field is moving toward multi-functional, adaptable designs to overcome tumor complexity.

vist.ly/5mcnu